Unknown

Dataset Information

0

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation.


ABSTRACT: Despite remarkable achievements in the treatment of hematologic malignancies, chimeric antigen receptor (CAR)-T cell therapy still faces many obstacles. The limited antitumor activity and persistence of infused CAR-T cells, especially in solid tumors, are the main limiting factors for CAR-T therapy. Moreover, clinical security and accessibility are important unmet needs for the application of CAR-T therapy. In view of these challenges, many potentially effective solutions have been proposed and confirmed. Both the independent and combined strategies of CAR-T therapy have exhibited good application prospects. Thus, in this review, we have discussed the cutting-edge breakthroughs in CAR-T therapy for cancer treatment, with the aim of providing a reference for addressing the current challenges.

SUBMITTER: Guo F 

PROVIDER: S-EPMC8072891 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6548503 | biostudies-literature
| S-EPMC7330881 | biostudies-literature
| S-EPMC5300200 | biostudies-literature
2014-05-01 | E-GEOD-57212 | biostudies-arrayexpress
2024-02-24 | GSE226224 | GEO
2014-05-01 | E-GEOD-57210 | biostudies-arrayexpress
2014-05-01 | E-GEOD-57209 | biostudies-arrayexpress
2014-05-01 | E-GEOD-57211 | biostudies-arrayexpress
| S-EPMC8782435 | biostudies-literature
2014-05-01 | GSE57212 | GEO